EP-SOGO None

EP-SOGO is a company in Japan that supports clinical research and new drug development. The company is adapting to changes in the drug development industry, including a shift towards cancer, CNS, and rare diseases, as well as the emergence of new cell and gene technologies. To keep up with these changes, EP-SOGO is improving the expertise of its CRCs through disease training and participation in conferences. The company is also streamlining clinical trial operations and collaborating with EPS group company affiliates. EP-SOGO's corporate philosophy is to improve daily and provide ever-progressing services while maintaining core values.

Headquarters: Tokyo, Tokyo, Japan
Estimated Revenue: RM100, ~S$32.91